Allworth Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479 | Buy |
+75
| New | +$479 | ﹤0.01% | 4141 |
|
|
2023
Q3 | – | Sell |
-21
| Closed | -$155 | – | 3467 |
|
|
2023
Q2 | $155 | Buy |
+21
| New | +$155 | ﹤0.01% | 3137 |
|
|
2023
Q1 | – | Sell |
-92
| Closed | -$1.09K | – | 3227 |
|
|
2022
Q4 | $1.09K | Buy |
92
+85
| +1,214% | +$1K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $0 | Buy |
7
+1
| +17% | – | ﹤0.01% | 2766 |
|
|
2022
Q2 | $0 | Buy |
6
+2
| +50% | – | ﹤0.01% | 2497 |
|
|
2022
Q1 | $0 | Sell |
4
-191
| -98% | – | ﹤0.01% | 2180 |
|
|
2021
Q4 | $8K | Buy |
+195
| New | +$8K | ﹤0.01% | 1463 |
|
|
2021
Q3 | – | Sell |
-130
| Closed | -$8K | – | 1895 |
|
|
2021
Q2 | $8K | Hold |
130
| – | – | ﹤0.01% | 1094 |
|
|
2021
Q1 | $12K | Hold |
130
| – | – | ﹤0.01% | 930 |
|
|
2020
Q4 | $12K | Hold |
130
| – | – | ﹤0.01% | 787 |
|
|
2020
Q3 | $13K | Hold |
130
| – | – | ﹤0.01% | 650 |
|
|
2020
Q2 | $10K | Hold |
130
| – | – | ﹤0.01% | 723 |
|
|
2020
Q1 | $8K | Buy |
+130
| New | +$8K | ﹤0.01% | 744 |
|